Nokea
The U.S. Drug Enforcement Administration:
- A. Registers manufacturers and prescribers of controlled substances
- B. Regulates NP prescribing at the state level
- C. Sanctions providers who prescribe drugs off-label
- D. Provides prescribers with a number they can use for insurance billing
Correct Answer: A
Rationale: The DEA registers those handling controlled substances , not state NP rules , off-label sanctions , or insurance numbers .
You may also like to solve these questions
Carbamazepine has a Black Box Warning recommending testing for the HLA-B*1502 allele in patients with Asian ancestry prior to starting therapy due to:
- A. Decreased effectiveness of carbamazepine in treating seizures in Asian patients with HLA-B*1502 allele
- B. Increased risk for drug interactions in Asian patients with the HLA-B*1502 allele
- C. Increased risk for Stevens-Johnson syndrome in Asian patients with HLA-B*1502 allele
- D. Patients who have the HLA-B*1502 allele being more likely to have a resistance to carbamazepine
Correct Answer: C
Rationale: HLA-B*1502 in Asians increases Stevens-Johnson syndrome risk with carbamazepine , per FDA warning, not efficacy or interactions .
A nurse is preparing a client's medications. Which of the following actions should the nurse take in following legal practice guidelines? (Select ONE that does not apply.)
- A. Maintain skill competency.
- B. Determine the dosage.
- C. Monitor for adverse effects.
- D. Safeguard medications.
Correct Answer: B
Rationale: Nurses must maintain competency , monitor effects , and safeguard meds ; determining dosage is the prescriber's role.
All of following drugs are metabolized in body by acetylation except:
- A. INH
- B. Hydralazine
- C. Procainamide
- D. Dilantin
Correct Answer: D
Rationale: Dilantin (phenytoin) is metabolized by hydroxylation, not acetylation.
A nurse is caring for a client who has increased intracranial pressure and is receiving Mannitol. Which of the following findings should the nurse report to the provider?
- A. Blood glucose 150 mg/dL
- B. Urine output 40 mL/hr
- C. Dyspnea
- D. Bilateral equal pupil size
Correct Answer: C
Rationale: Dyspnea may indicate pulmonary edema, a potential complication of mannitol therapy.
A patient is diagnosed with tinea capitis. The provider will order which systemic antifungal medication for this patient?
- A. Anidulafungin (Eraxis)
- B. Fluconazole (Diflucan)
- C. Griseofulvin (Fulvicin)
- D. Ketoconazole (Nizoral)
Correct Answer: C
Rationale: Griseofulvin treats tinea capitis systemically; fluconazole or ketoconazole are less specific. Griseofulvin is used to treat tinea capitis.